| 9296710 |
Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist |
Teresa Tse Ki Man, James Allen Monn, Carlos Montero Salgado, Lourdes Prieto, Lesley Walton |
2016-03-29 |
$235,215,000 |
| 8168659 |
1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators |
David Scott Coffey, Jingdan Hu, Stacy Jo Keding, Joseph H. Krushinski, Jr., John M. Schaus |
2012-05-01 |
$207,727,000 |
| 7384934 |
Piperazine substituted aryl benzodiazepines |
Thomas D. Aicher, Zhaogen Chen, Yvan LeHuerou, Fionna Mitchell Martin, Marta Pineiro-Nunez +4 more |
2008-06-10 |
$65,113,000 |
| RE40033 |
Process for preparing 2-methyl-thieno-benzodiazepine |
Jiban K. Chakrabarti, Terrence M. Hotten |
2008-01-22 |
|
| 7303764 |
2-methyl-thieno-benzodiazepine formulation |
Douglas J. M. Allen, Kurt Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray +6 more |
2007-12-04 |
$101,623,000 |
| 7214673 |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
Thomas D. Aicher, Zhaogen Chen, Joseph H. Krushinski, Jr., Yvan Le Huerou, Marta Pineiro-Nunez +6 more |
2007-05-08 |
$92,297,000 |
| 6617321 |
2-methyl-thieno-benzodiazepine formulation |
Douglas J. M. Allen, Kurt Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray +6 more |
2003-09-09 |
$63,645,000 |
| 6384281 |
3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
Martine Keenan, Sandra Ginette Milutinovic |
2002-05-07 |
$76,358,000 |
| 6169084 |
2-methyl-thieno-benzodiazepine formulation |
Charles A. Bunnell, Thomas H. Ferguson, Barry A. Hendriksen, Manuel V. Sanchez-Felix |
2001-01-02 |
$613,599,000 |
| 6034078 |
Thienobenzodiazepine compounds |
John Fairhurst, Terrence M. Hotten, David T. Wong |
2000-03-07 |
$113,850,000 |
| 6008216 |
Process for preparing 2-methyl-thieno-benzodiazepine |
Jiban K. Chakrabarti, Terrence M. Hotten |
1999-12-28 |
$78,907,000 |
| 5817655 |
Methods of treatment using a thieno-benzodiazepine |
Jiban K. Chakrabarti, Terrence Micharl Hotten |
1998-10-06 |
$82,345,000 |
| 5817656 |
Mental disorders |
Charles M. Beasley, Jr., Jiban K. Chakrabarti, Terrence M. Hotten |
1998-10-06 |
$82,345,000 |
| 5817657 |
Psychoactive substance disorders |
Charles M. Beasley, Jr., Jiban K. Chakrabarti, Terrence M. Hotten |
1998-10-06 |
$82,345,000 |
| 5703232 |
Process and solvate of 2-methyl-thieno-benzodiazepine |
Charles A. Bunnell, Terrence M. Hotten, Samuel Dean Larsen |
1997-12-30 |
$158,699,000 |
| 5631250 |
Process and solvate of 2-methyl-thieno-benzodiazepine |
Charles A. Bunnell, Terrence M. Hotten, Samuel Dean Larsen |
1997-05-20 |
|
| 5627178 |
2-methyl-thieno-benzodiazepine |
Jiban K. Chakrabarti, Terrence M. Hotten |
1997-05-06 |
$2,977,000 |
| 5605897 |
2-methyl-thieno-benzodiazepine |
Charles M. Beasley, Jr., Jiban K. Chakrabarti, Terrence M. Hotten |
1997-02-25 |
|
| 5389684 |
Naphthalene carboxamides |
John Fairhurst |
1995-02-14 |
$3,939,000 |
| 5338735 |
Pharmaceutical compounds |
John Fairhurst |
1994-08-16 |
$3,031,000 |
| 5258378 |
Pyrroloazepine compounds useful as dopaminergic agents |
Barry Peter Clark, Graham H. Timms |
1993-11-02 |
$3,375,000 |
| 5229382 |
2-methyl-thieno-benzodiazepine |
Jiban K. Chakrabarti, Terrence M. Hotten |
1993-07-20 |
$2,512,000 |
| 5041461 |
Organic compounds and their use as pharmaceuticals |
Maria Isabel Fernandez Fernandez, Terrence M. Hotten |
1991-08-20 |
$1,387,000 |
| 5028602 |
Pharmaceutical compounds |
Barry Peter Clark |
1991-07-02 |
$1,361,000 |
| 5021449 |
Organic compounds and their use as pharmaceuticals |
Maria Isabel Fernandez Fernandez, Terrence M. Hotten |
1991-06-04 |
$729,000 |
